Brief Pain Inventory (BPI) Scale
Overview and Structure
The Brief Pain Inventory (BPI) is a validated self-report questionnaire that measures both pain intensity (sensory dimension) and pain interference with daily function (reactive dimension), originally developed for cancer patients but now validated across multiple pain conditions including arthritis, low back pain, postoperative pain, and cardiac surgery. 1, 2, 3
The BPI consists of:
- Pain severity items: Four questions rating pain at its worst, least, average, and current intensity on a 0–10 numeric scale 1, 2
- Pain interference items: Seven questions assessing how pain interferes with general activity, mood, walking ability, normal work, relations with others, sleep, and enjoyment of life, each rated 0–10 1, 2
- Additional domains: Questions about pain relief from treatments, pain quality descriptors, and patient perception of pain cause 1
Administration
The BPI is a short, self-administered questionnaire that patients complete independently, typically requiring 2–5 minutes for the short form 4. Multiple validated translations exist in over 53 languages, including Brazilian, Chinese, Greek, Hindi, Italian, Japanese, Korean, Malay, Norwegian, Polish, Russian, Spanish, Taiwanese, and Thai 4, 2.
Critical limitation: The BPI requires patients who can reliably self-report pain; it is unsuitable for patients with aphasia, altered consciousness, delirium, or any inability to communicate 5, 6. For non-communicative ICU patients, use validated behavioral scales such as the Behavioral Pain Scale for Non-Intubated patients (BPS-NI) or Critical-Care Pain Observation Tool (CPOT) instead 5, 7.
Scoring
Pain Severity Score
- Calculate the mean of the four pain intensity items (worst, least, average, current pain) 2, 3
- Scores range from 0 (no pain) to 10 (worst possible pain) 2
Pain Interference Score
- Calculate the mean of the seven interference items 2, 3
- Scores range from 0 (no interference) to 10 (complete interference) 2
Both scales demonstrate high internal consistency with Cronbach's alpha coefficients between 0.84–0.94, supporting their reliability 8, 3.
Interpretation
Pain Severity Categories
Using the 0–10 scale:
Clinically Meaningful Change
A reduction of ≥1 point (≥10 mm on a 100 mm scale) represents the minimal clinically important difference (MCID) that patients perceive as meaningful improvement 9. This threshold guides whether analgesic adjustments are warranted 9.
Functional Impact Assessment
Higher pain interference scores indicate greater disruption to daily activities, work, relationships, and quality of life 1, 2. The BPI's ability to capture both pain intensity and functional impact makes it superior to simple numeric scales that assess severity alone 10, 4.
Psychometric Properties
The BPI demonstrates:
- Strong construct validity: Factor analysis consistently confirms the two-factor structure (pain severity and interference) across diverse populations 8, 3
- Excellent criterion validity: Correlations of 0.47–0.65 with the SF-36 Bodily Pain dimension 8, 3
- Good responsiveness: Significant score reductions following effective treatment interventions 8, 3
- Reliability across conditions: Validated in cancer pain, osteoarthritis, low back pain, cardiac surgery, and postpartum pain 2, 11, 8, 3
Clinical Applications
The BPI is recommended for:
- Clinical pain assessment in outpatient and inpatient settings 1, 2
- Epidemiological studies of pain prevalence and burden 1, 2
- Treatment effectiveness trials as a primary or secondary outcome measure 1, 2
- Postpartum pain assessment, where the Short-Form BPI (SF-BPI) received a Class A recommendation as the best available tool 4
Key Advantages Over Other Pain Scales
The BPI assesses nine distinct pain domains (severity, location, quality, relief, exacerbating/relieving factors, medications, and functional interference), making it more comprehensive than simple numeric rating scales or visual analog scales that capture only intensity 10, 4. This multidimensional assessment is particularly valuable for chronic pain conditions where functional impact drives treatment decisions 10, 4.
Important Caveats
- Three questions in the full BPI reference "diagnosis" and "primary disease," which are not applicable to postpartum or acute pain populations; the Short-Form BPI eliminates these items 4
- The BPI does not assess pain interference with infant care, cognitive function, fatigue, or sexual function—domains relevant to specific populations like postpartum women 4
- For daily pain monitoring in clinical trials, a modified BPI with items referring to "changes in pain associated with medication use" has been validated and minimizes patient burden 11
- The BPI requires observable patient responses; it cannot be used in deeply sedated or paralyzed patients 5, 7